Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Obesity 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 535Carboplatin 533Cisplatin 480pembrolizumab 457Gemcitabine 422Docetaxel 416Rituximab 386Radiotherapy 373Dexamethasone 352Doxorubicin 330Nivolumab 309Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × dapagliflozin × Clear all
NCT04542291 2023-02-14

Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition

Washington University School of Medicine

Phase 1 Completed
15 enrolled 15 charts
Gastrointestinal

Pancreatic Neoplasms

NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Woman's

Phase 3 Completed
119 enrolled 34 charts
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡